Discover more insights into Trials Consortium

Keywords frequently search together with Trials Consortium

Narrow sentence examples with built-in keyword filters

Trials Consortium sentence examples within Clinical Trials Consortium



UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Reflux Scale correlates with impaired Esophageal Scintigraphy findings in Systemic Sclerosis.



Protocols for multi-site trials using hyperpolarized 129 Xe MRI for imaging of ventilation, alveolar-airspace size, and gas exchange: A position paper from the 129 Xe MRI clinical trials consortium.


Trials Consortium sentence examples within Tuberculosi Trials Consortium



Optimising pyrazinamide for the treatment of tuberculosis



Optimizing drug inventory management with a web-based information system: The TBTC study 31/ACTG A5349 experience.


Trials Consortium sentence examples within Health Trials Consortium



A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study



Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study



Learn more from Trials Consortium


Trials Consortium sentence examples within trials consortium gastrointestinal



UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Reflux Scale correlates with impaired Esophageal Scintigraphy findings in Systemic Sclerosis.



AB0415 ANXIETY AND DEPRESSION IN SSc – ASSESSING FUNCTION, QUALITY OF LIFE AND GASTROINTESTINAL INVOLVEMENT


Trials Consortium sentence examples within trials consortium conducted



Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial



Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma



UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Reflux Scale correlates with impaired Esophageal Scintigraphy findings in Systemic Sclerosis.



Protocols for multi-site trials using hyperpolarized 129 Xe MRI for imaging of ventilation, alveolar-airspace size, and gas exchange: A position paper from the 129 Xe MRI clinical trials consortium.


More Trials Consortium sentence examples
10.1183/13993003.02013-2020

Optimising pyrazinamide for the treatment of tuberculosis


More Trials Consortium sentence examples
10.1136/ANNRHEUMDIS-2021-EULAR.849

AB0413 HIGH-RESOLUTION COMPUTED TOMOGRAPHY FOR THE SCREENING, RE-SCREENING AND FOLLOW-UP OF SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE: RESULTS OF A EUSTAR-SCTC SURVEY


More Trials Consortium sentence examples
10.1016/j.cct.2021.106377

Optimizing drug inventory management with a web-based information system: The TBTC study 31/ACTG A5349 experience.


More Trials Consortium sentence examples
10.1016/j.cct.2021.106355

Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis.


More Trials Consortium sentence examples
10.1038/s41591-020-01193-6

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial


More Trials Consortium sentence examples
10.1200/JCO.2021.39.15_SUPPL.5012

Interim results of aasur: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA+P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa).


More Trials Consortium sentence examples
10.1136/ANNRHEUMDIS-2021-EULAR.585

POS0324 SMOKING HISTORY AND SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI) AS INDEPENDENT PREDICTORS OF MORTALITY IN SYSTEMIC SCLEROSIS IN A SINGLE-CENTRE ITALIAN COHORT


More Trials Consortium sentence examples
10.1136/ANNRHEUMDIS-2021-EULAR.1166

AB0415 ANXIETY AND DEPRESSION IN SSc – ASSESSING FUNCTION, QUALITY OF LIFE AND GASTROINTESTINAL INVOLVEMENT


More Trials Consortium sentence examples
10.1186/s11689-021-09373-2

Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium


More Trials Consortium sentence examples
10.1136/ANNRHEUMDIS-2021-EULAR.582

OP0273 THE SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI) IN A SYSTEMIC SCLEROSIS COHORT WITH 10-YEARS FOLLOW-UP


More Trials Consortium sentence examples
10.1016/j.euroneuro.2021.02.020

A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders


More Trials Consortium sentence examples
10.1136/ANNRHEUMDIS-2021-EULAR.1177

AB0417 COMPARATIVE ANALYSIS OF THE FREQUENCY OF GASTRO-INTESTINAL SYMPTOMS IN THE CLINICAL EVALUATION VERSUS WITH UCLA SCTC GIT 2.0


More Trials Consortium sentence examples
10.1200/JCO.2021.39.15_SUPPL.TPS5095

Open label phase II trial of cabozantinib (cabo) in patients with metastatic castrate resistant prostate cancer (mCRPC) and known amplifications or activating mutations in gene targets who have received prior anti-androgen therapy.


More Trials Consortium sentence examples
10.1136/annrheumdis-2019-eular.3531

FRI0310 UNIVERSITY OF CALIFORNIA LOS ANGELES SCLERODERMA CLINICAL TRIALS CONSORTIUM GASTROINTESTINAL TRACT 2.0 REFLUX-SCALE ASSOCIATES WITH IMPAIRED ESOPHAGEAL SCINTIGRAPHY FINDINGS IN SYSTEMIC SCLEROSIS


More Trials Consortium sentence examples
10.1016/j.autrev.2018.10.006

Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature.


More Trials Consortium sentence examples
10.1016/S1473-3099(19)30423-2

A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study



Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma


More Trials Consortium sentence examples
10.1136/annrheumdis-2018-214764

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis


More Trials Consortium sentence examples
10.1158/1538-7445.AM2019-CT233

Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial



Investigator-Initiated Registration Directed Trials, or Advanced Medical Care conducted by GOTIC and NRG-Oncology Japan


More Trials Consortium sentence examples
10.1093/rheumatology/kez160

Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial.


More Trials Consortium sentence examples
10.1016/S1473-3099(18)30753-9

Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study


More Trials Consortium sentence examples
10.1016/J.EJSO.2019.07.008

Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM).


More Trials Consortium sentence examples
10.1177/2397198318783926

An interim report of the Scleroderma Clinical Trials Consortium working groups


More Trials Consortium sentence examples
10.1038/s41591-018-0337-7

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma


More Trials Consortium sentence examples
10.1016/J.CLGC.2019.04.013

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.


More Trials Consortium sentence examples
10.1136/annrheumdis-2019-215588

Differentiating disease activity from damage in systemic sclerosis: it’s still early days!


More Trials Consortium sentence examples
10.1177/1740774519885380

Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen


Learn more from Trials Consortium


Trials Consortium
Encyclopedia